MDT Medtronic plc

99.94USD-0.67%Mkt Cap: 127.84B USDP/E: 24.56

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three seg…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap127.84B USD
Enterprise Value148.65B USD
Revenue (TTM)37.54B USD
Gross Profit23.64B USD
Net Income (TTM)4.80B USD
Revenue/Share29.30 USD
Last Price99.94 USD
Fiscal Year EndApr 2026
MR QuarterJul 2026
Employees95.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)24.56
P/E (Forward)15.60
PEG1.81
EV/EBITDA14.30
EV/Revenue3.96
P/S3.41
P/B2.55
EPS (TTM)4.07 USD
EPS (Forward)6.41 USD
52W Range
73.3181% of range106.33
52W High106.33 USD
52W Low73.31 USD
Profitability
Gross Margin65.02%
Oper. Margin20.05%
EBITDA Margin27.68%
Profit Margin13.20%
ROE9.71%
ROA5.16%
ROIC7.82%
ROCE8.39%
Growth
Revenue Growth13.70%
Earnings Growth40.70%
Cash Flow & Leverage
Operating CF7.33B USD
CapEx (TTM)1.90B USD
FCF Margin14.39%
FCF Yield4.23%
Net Debt19.33B USD
Net Debt/EBITDA1.86
Net Debt/FCF3.58
Balance Sheet
Debt/Equity0.57
Current Ratio2.07
Quick Ratio1.29
Book Value/Sh39.24 USD
Cash/Share6.89 USD
Dividends
Fwd Div Rate2.88 USD
Trail. Div Rate2.85 USD
Div. Yield2.86%
5Y Avg Yield3.07%
Payout Ratio70.02%
Ex-Div DateSep 25, 2026
Pay DateOct 16, 2026
Splits
Last Split2:1
Split DateSep 27, 1999
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)106.96 USD
Upside (mean)+7.0%
Target Range92.00 USD – 121.00 USD
92.00+7.0% to mean121.00
# Analysts26
Ownership
Shares Out.1.28B
Float1.28B
Insiders0.42%
Institutions92.62%
Short Interest
Short Ratio0.8d
Short % Float1.80%
Short % Out.1.79%
Shares Short22.95M
Short (prev mo.)39.97M
Technical
SMA 5094.27 (+6.0%)
SMA 20088.25 (+13.3%)
Beta0.57
S&P 52W Chg12.00%
Avg Vol (30d)11.58M
Avg Vol (10d)6.47M
Technical Indicators
RSI (14)53.8
MACD1.9671
MACD Signal2.4431
MACD Hist.-0.4760
BB Upper106.66 USD
BB Middle100.16 USD
BB Lower93.67 USD
BB Width12.97%
ATR (14)2.394 USD
Vol Ratio (20d)1.26x

About Medtronic (NYSE: MDT)

›

Medtronic (NYSE: MDT) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 95,000 employees.

The shares were at 99.94 USD on 20 November 2026, up 2.1% over 52 weeks. Its 52-week range is 73.31 USD to 106.33 USD: the price is 6.0% below the high and 36.3% above the low.

At a market capitalisation of 127.84B USD, it trades at 24.6 times trailing earnings and 15.6 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.5, so MDT is valued in line with them. It pays a dividend yielding 2.86% (it pays out 70% of its earnings), against a median of 2.28% among the dividend payers in that peer group.

Medtronic reports return on equity of 9.7%, an operating margin of 20.1% and revenue up 13.7% year over year.

Its debt exceeds its cash by 19.33B USD, a debt-to-equity ratio of 0.57. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 26 analysts cover the stock, with an average rating of Buy; their mean price target of 106.96 USD is 7.0% above the current price.